semaglutide news today 2025 just got FDA-approved for kidney disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in Compounded GLP-1 Ban: What I

No matter the size youre working with, you should fully insert the needle subcutaneously (meaning through the outer layer of skin, but not into muscle) at a 90-degree angle

This allows us to adjust your plan based on whats actually changing in your body

doi:10.1016/j.bcp.2015.07.012 Zhao JV, Yeung WF, Chan YH, et al

This choice ensures consistency in dosing, safety, and efficacy

Yes, the glucagon receptor activation in retatrutide may increase resting energy expenditure and promote thermogenesis, meaning the body burns more calories at rest compared to GLP-1-only medications like semaglutide

They are expressed in salivary gland tissue